Using MRI and blood tests to detect aggressive prostate cancer early
MRI Imaging and Biomarkers for Early Detection of Aggressive Prostate Cancer
This study is looking for better ways to spot aggressive prostate cancer early using advanced MRI scans and blood tests, so men can avoid unnecessary biopsies and get the right treatment based on a new scoring system that helps identify cancer risks.
Quick facts
| Grant type | U01 cooperative agreement |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Miami School of Medicine NIH-funded |
| Lab location | 1 site (Coral Gables, United States) |
| Project ID | NIH-10695064 on NIH RePORTER |
What this research studies
This research focuses on improving the early detection of aggressive prostate cancer by utilizing advanced MRI techniques and blood biomarkers. The study aims to reduce unnecessary biopsies by enhancing the accuracy of identifying significant cancer risks through a novel automated analysis system. Collaborations with various institutions will help validate these methods, which include a new scoring system for assessing prostate cancer risk. Patients will be monitored to determine the effectiveness of these approaches in distinguishing between aggressive and non-aggressive forms of cancer.
Who could benefit from this research
Good fit: Ideal candidates for this research are men who are at risk for prostate cancer and may require evaluation for aggressive forms of the disease.
Not a fit: Patients who have already been diagnosed with advanced prostate cancer or those with non-aggressive forms of the disease may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to fewer unnecessary biopsies and better-targeted treatments for patients at risk of aggressive prostate cancer.
How similar studies have performed: Previous research has shown promise in using MRI and biomarkers for cancer detection, indicating that this approach could be a significant advancement in prostate cancer diagnostics.
Where this research is happening
Coral Gables, United States
- University of Miami School of Medicine — Coral Gables, United States (Active)
Researchers
- Principal investigator: Pollack, Alan — University of Miami School of Medicine
- Study coordinator: Pollack, Alan
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.